Here are Friday's biggest analyst calls: Nvidia, SpaceX, Tesla, Boeing, Apple, American Express & more

Wall Street firms issued a broadly positive set of initiations, upgrades and reiterations, including overweight or buy calls on American Express, Boeing, CBOE, Humana, Fastly and Nvidia. Price targets included $300 for Boeing, $596 for Humana and $35 for Fastly; Ducommun’s $246 target was described as implying 46% upside. Analysts cited, among other factors, AI-related demand for Nvidia and early monetization of agentic-AI traffic at Fastly; the article reports no stock-price reactions.

Analysis

This is a low-conviction, broker-opinion catalyst rather than a broad fundamental signal: the mildly positive tone should not be treated as evidence of estimate revisions or durable demand. The more interesting dispersion is between businesses with measurable near-term operating tests and long-duration narratives. Cboe’s upside case depends on sustained options/market activity; normalization in volatility and volumes would quickly weaken it. Fastly’s agentic-AI thesis is more speculative: traffic only matters if it converts into security attach, contract value, and recognized revenue, so the key risk is multiple expansion ahead of monetization. ArcelorMittal’s setup is cyclical, not simply a rebound trade—EU hot-rolled coil pricing and imports must confirm the proposed recovery, while weaker industrial demand or added supply can reverse it.

Over days, fresh ratings may move smaller or less-followed names, but that reaction is vulnerable to fading absent estimate changes. Over 1–3 months, prioritize reported operating indicators over analyst language; over 6–18 months, AI monetization and healthcare/policy outcomes remain the larger, less verifiable drivers. Contrarian point: the breadth of bullish calls can create a crowded “buy the dip” framing, while the cited price targets and qualitative checks are not independent confirmation. Avoid a basket trade; favor conditional, catalyst-led exposure and define exits by fundamentals, not target prices.

Key Decisions for Investors

• CBOE: consider a measured long on weakness rather than chasing the upgrade. Reassess if options volume/market activity rolls over or earnings guidance fails to show operating leverage; the thesis is activity-sensitive, not a guaranteed volatility hedge.
• Fastly: keep on a confirmation watch, not an immediate high-conviction long. Require subsequent disclosures to show security-product attach, contract-value growth, and AI-related traffic translating into revenue; if traffic rises without monetization, avoid or fade the narrative premium.
• ArcelorMittal: tactical long only if EU hot-rolled coil prices strengthen and remain supported by demand; otherwise the pullback may reflect more than an entry opportunity. Falsifiers include continued price weakness, rising imports, or deteriorating industrial indicators.
• Do not trade the analyst-call list as a portfolio basket. For AXP, HUM, BA, and the biotech names, verify estimate revisions, regulatory/operating milestones, and valuation before acting; the article provides no independent evidence that the cited theses have changed fundamentals.